million, increased from the same quarter of the prior year Baht 43.72 million or 48.00%. The gross profit margin for Q1/2021 is approximately 9.79% compared with the same quarter of the prior year at 12. 39
1,577 1,542 (2%) 61% 3,014 4,172 38% Gross profit margin (%) 24% 30% 28% (2%) 4% 27% 29% 2% Net profit margin (%) 13% 5% 5% 0% (8%) 15% 6% (9%) Adjusted Net Income margin (%) 13% 7% 7% 0% (6%) 15% 8% (7
investment units. 1.3 Interest on margin loans The Company’s interest on margin loans in first quarter of 2019 was Baht 34 million, a decrease of 25 percent compared to the first quarter of the previous year
้ (Cross Rate) (2) คูณสินทรัพยแ์ต่ละรายการดว้ยน ้าหนกัความเส่ียงตามท่ีก าหนด (3) คูณภาระผกูพนัแต่ละรายการดว้ยค่าแปลงสภาพ (Credit Conversion Factor) ตามท่ี ก าหนดไวใ้นหวัขอ้รายละเอียดการแปลงค่าภาระผกูพนัเป็นจ
enhance more value to the customers resulted in a continuous growth in ARPU. The focus on quality also extended to subsidy optimization, leading to an improved sales margin of almost 5% for 1Q24. AIS
same period of 2017, due to the increasing of the quantity of Sales by 17%. 2. Cost of goods sold was Baht 1,275.68 million which the gross profit margin was decreased to 10.06% when compare to the same
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2
THB 13.4 million or 10.9% and gross profit margin to total revenues was at 15.4%. The Group reported total net profit for the year 2018 at THB 20.6 million, decreased by THB 29.8 million or 59.1% when
154.18 Administration expense 15.89 11.98 30.99 19.01 158.76 15.10 94.99 Net Profit -0.97 13.76 30.91 17.15 124.66 31.88 1,643.30 Gross Profit Margin (%) 5.61 20.08 18.04 -2.04 -10.18 12.43 221.57 Net
-18.38 -68.27 5.18 154.18 Administration expense 15.89 11.98 30.99 19.01 158.76 15.10 94.99 Net Profit -0.97 13.76 30.91 17.15 124.66 31.88 3,286.60 Gross Profit Margin (%) 5.61 20.08 18.04 -2.04 -10.18